Skip to main content
Enter a keyword
  • Login
  • Home

    Main navigation

    Menu
    • US Law
      • Chapter 15 Cases
    • Regions
      • Africa
      • Asia Pacific
      • Europe
      • North Africa/Middle East
      • North America
      • South America
    • Headlines
    • Education Resources
      • ABI Committee Articles
      • ABI Journal Articles
      • Covid 19
      • Conferences and Webinars
      • Newsletters
      • Publications
    • Events
    • Firm Articles
    • About Us
      • ABI International Board Committee
      • ABI International Member Committee Leadership
    • Join
    Restructuring Update: Third-Party Releases after Purdue Pharma - Solutions in Irish Law
    2024-11-07

    In Harrington v Purdue Pharma,1 the United States Supreme Court held that so-called “non-consensual third-party releases” were not permitted in restructuring plans proposed under Chapter 11 of the US Bankruptcy Code. A “third-party release” arises where creditors are asked to vote on a restructuring plan or scheme which not only proposes to release the debtor company (i.e. the company that has petitioned for bankruptcy or is proposing the scheme) from all liability but to also release other third parties from any associated liability.

    Filed under:
    Ireland, United Kingdom, USA, Insolvency & Restructuring, Litigation, McCann FitzGerald LLP, Companies Act 2006 (UK), Insolvency Regulation (1346/2000) (EU), Supreme Court of the United States, Pharmaceuticals
    Authors:
    Michael Murphy , Simon Walsh
    Location:
    Ireland, United Kingdom, USA
    Firm:
    McCann FitzGerald LLP
    From Opioids to Opt-Outs: Nonconsensual Third-Party Releases and the Aftermath of Purdue
    2024-10-28

    On June 27, 2024, the U.S. Supreme Court released its 5-4 opinion in connection with the bankruptcy case of Purdue Pharma L.P. (“Purdue”). Over a vigorous dissent authored by Justice Kavanaugh, a narrow majority of the Supreme Court held that the Bankruptcy Code does not permit chapter 11 plans of reorganization to provide for non-consensual releases of non-debtors outside of the asbestos context.

    Filed under:
    USA, Insolvency & Restructuring, Litigation, Proskauer Rose LLP, Mediation, US Congress, Congress, Supreme Court of the United States, Pharmaceuticals
    Authors:
    Paul V. Possinger , Elliot R. Stevens
    Location:
    USA
    Firm:
    Proskauer Rose LLP
    Supreme Court Ends Third-Party Releases in Bankruptcy
    2024-09-26

    Harrington v. Purdue Pharma L.P., 144 S. Ct. 2017 (June 27, 2024)

    Filed under:
    USA, Insolvency & Restructuring, Litigation, Frost Brown Todd LLP, Chapter 11, US Bankruptcy Code, Supreme Court of the United States, Pharmaceuticals, Pharmaceuticals & chemicals
    Authors:
    Mark A. Platt , Joy D. Kleisinger
    Location:
    USA
    Firm:
    Frost Brown Todd LLP
    SCOTUS Issues Ruling in Purdue Pharma Case and Concludes that a Bankruptcy Plan Cannot Include Nonconsensual Third-Party Releases
    2024-07-01

    On June 27, 2024, the United States Supreme Court issued its decision in Harrington v. Purdue Pharma LP, addressing the question of whether a company can use bankruptcy to resolve the liability of non-debtor third parties. The Supreme Court, in a 5-4 decision, held that the bankruptcy code does not authorize a release and an injunction that, as part of a plan of reorganization under Chapter 11, effectively seek to discharge the claims against a nondebtor without the consent of the affected claimants.

    Filed under:
    USA, Insolvency & Restructuring, Litigation, Hunton Andrews Kurth LLP, Bankruptcy, Insolvency, Supreme Court of the United States, Pharmaceuticals
    Authors:
    Gregory G. Hesse
    Location:
    USA
    Firm:
    Hunton Andrews Kurth LLP
    Second Circuit Approves Nonconsensual Third-Party Release in Purdue Pharma Case: Where Do Third Party Releases Stand Now?
    2023-06-08

    In an anticipated decision, on May 30, 2023, the Second Circuit Court of Appeals issued its decision approving a Chapter 11 plan’s inclusion of a nonconsensual release of direct claims against non-debtor third parties. Purdue Pharma LP v. City of Grand Prairie (In re Purdue Pharma LP), No. 22-110 (2d Cir. May 30, 2023).

    Filed under:
    USA, Insolvency & Restructuring, Litigation, Hunton Andrews Kurth LLP, Pharmaceuticals, Second Circuit
    Authors:
    Gregory G. Hesse , Kollin Bender
    Location:
    USA
    Firm:
    Hunton Andrews Kurth LLP
    Home

    Quick Links

    • US Law
    • Headlines
    • Firm Articles
    • Board Committee
    • Member Committee
    • Join
    • Contact Us

    Resources

    • ABI Committee Articles
    • ABI Journal Articles
    • Conferences & Webinars
    • Covid-19
    • Newsletters
    • Publications

    Regions

    • Africa
    • Asia Pacific
    • Europe
    • North Africa/Middle East
    • North America
    • South America

    © 2025 Global Insolvency, All Rights Reserved

    Joining the American Bankruptcy Institute as an international member will provide you with the following benefits at a discounted price:

    • Full access to the Global Insolvency website, containing the latest worldwide insolvency news, a variety of useful information on US Bankruptcy law including Chapter 15, thousands of articles from leading experts and conference materials.
    • The resources of the diverse community of United States bankruptcy professionals who share common business and educational goals.
    • A central resource for networking, as well as insolvency research and education (articles, newsletters, publications, ABI Journal articles, and access to recorded conference presentation and webinars).

    Join now or Try us out for 30 days